
Sign up to save your podcasts
Or


The World Health Organization conditionally recommended glucagon-like peptide-1 (GLP-1) therapies for obesity treatment in December 2025. Canada could soon become the first country in the world to offer a cheaper version of Ozempic and Wegovy to people with prescriptions.
Our question: Would you take a drug to lose weight...or have you already?
By CBC3.8
1111 ratings
The World Health Organization conditionally recommended glucagon-like peptide-1 (GLP-1) therapies for obesity treatment in December 2025. Canada could soon become the first country in the world to offer a cheaper version of Ozempic and Wegovy to people with prescriptions.
Our question: Would you take a drug to lose weight...or have you already?

428 Listeners

122 Listeners

378 Listeners

54 Listeners

366 Listeners

209 Listeners

71 Listeners

74 Listeners

27 Listeners

21 Listeners

166 Listeners

91 Listeners

432 Listeners

9 Listeners

16 Listeners

31 Listeners

204 Listeners

9 Listeners

96 Listeners

344 Listeners

4 Listeners

24 Listeners

65 Listeners

118 Listeners

4 Listeners

5 Listeners

4 Listeners

19 Listeners

4 Listeners